Your email address is safe with us. View our Privacy policy.
FDA announces LASIK investigation plans
The FDA said the study -- to be conducted with and co-funded by the National Eye Institute and the Department of Defense -- will focus on laser-assisted in situ keratomileusis, a surgical procedure that uses a laser to permanently change the shape of a person's cornea to improve their vision.
Officials said the goals of the project are to determine the percentage of patients with significant quality of life problems after undergoing LASIK and to identify predictors of such problems.
The project is composed of three phases. The objective of Phase 1, which began in July, was to design and implement a Web‑based questionnaire to assess patient-reported outcomes and evaluate quality of life issues post-LASIK.
Phase 2 will evaluate the quality of life and satisfaction following LASIK as reported by patients in a select, active duty population treated at the Navy Refractive Surgery Center. Phase 3 will be a national, multi-center clinical trial and will study LASIK's impact on the quality of life of patients in the general public.
The FDA also announced it issued warning letters to 17 unidentified LASIK ambulatory surgical centers after inspections revealed inadequate adverse event reporting systems at the facilities.
Copyright 2009 by United Press International
This news arrived on: 10/15/2009
Printer Friendly Version | Send this page to a friend | Post Comment
Rate This Story:
Great - 5 - 4 - 3 - 2 - 1 - Bad
Posted Comments:
Comment archive | Comment FAQ's
 |
 |
View Science & Technology ezine stories by date or visit the complete archive |
The ArcaMax Politics channel is one of 70 content categories offered by ArcaMax Publishing on this ... |
VideoSquares.com
